VP of Clinical Development

US (Remote)
Role Details
Position
VP of Clinical Development
Function
Clinical
Location
US (Remote)
Reports To
Chief Medical Officer

About the Job

The VP of Clinical Development (U.S.-based) is accountable for the integrated clinical strategy, scientific leadership, and delivery of the company’s pipeline of therapies targeting immune-mediated diseases. This executive will lead development from candidate selection and IND/CTA-enabling activities through first-in-human (FIH), Phase 1, Phase 1b proof-of-mechanism (PoM), and Phase 2a proof-of-concept (PoC) studies, with scope to continue into later-stage development as programs mature.

The role requires deep expertise in early clinical development, strong medical and scientific judgment, and the ability to translate emerging data into clear decisions on dose, schedule, patient population, endpoints, biomarkers, and indication strategy.

The VP of Clinical Development will oversee Clinical Leads and Clinical Scientists, establish rigorous standards for clinical plans and study design, and work in close partnership with Clinical Operations to deliver high-quality global trials across multiple geographies and regulatory landscapes.

Working through a cross-functional Clinical Development Team, the VP of Clinical Development will provide unified clinical and scientific leadership, integrating regulatory, CMC, safety, translational, operational, and commercial considerations into a coherent development strategy and executable plan.

This plan will reflect the program vision, Target Product Profile, and value proposition; define clear clinical objectives and decision criteria; identify and manage critical risks; and enable timely, evidence-based decisions at key investment and governance milestones.

The VP of Clinical Development will lead by influence across functions and geographies and directly oversee Clinical Leads and Clinical Scientists. They will establish clear accountabilities, high standards for clinical and scientific work, transparent decision-making, and strong execution discipline.

The role will partner closely with Clinical Operations on feasibility, site and vendor strategy, enrollment, trial management, timelines, budgets, and data quality while retaining accountability for clinical strategy, protocol design, medical oversight, benefit-risk assessment, and interpretation of clinical data.

The VP of Clinical Development will collaborate with Research, Pre-clinical Development, Translational Science, Biomarkers, Clinical Pharmacology, Regulatory, CMC, Safety, DMPK, Project Management, Finance, and Business Development and will represent clinical development at senior governance forums and with external partners. This role reports to the Chief Medical Officer.

Key Responsibilities

Clinical Development Strategy & Leadership

  • Global Strategy: Define and drive the global clinical development strategy for early-stage programs (FIH, Phase 1, Phase 1b PoM, Phase 2a PoC) with expansion into later-stage development as programs mature.
  • Team Leadership: Provide scientific leadership, coaching, and oversight to Clinical Leads and Clinical Scientists; ensure high-quality CDP, protocols, investigator brochures, analysis plans, and regulatory filings.
  • Operations & Vendor Governance: Partner with Clinical Operations on study execution (country/site selection, enrollment assumptions, timelines, budgets) and CRO/vendor selection, contracting, and governance.
  • Core Decisions: Drive key clinical decisions regarding dose selection, cohort design, target patient populations, endpoints, biomarker integration, and benefit-risk assessments for immune-mediated diseases.

Organizational Leadership, Quality & Safety

  • Team Building: Mentor a high-performing clinical team, define roles/decision rights, and foster a patient-focused, data-driven culture.
  • Compliance: Ensure all program activities comply with ICH-GCP, GMP, regulatory expectations, ethical standards, and safety principles, rapidly escalating any issues.

Pre-clinical Development & Transition to Clinic

  • Candidate-to-Clinic Execution: Lead integrated transition planning from candidate selection through IND/CTA clearance and FIH initiation with clear milestones, governance, and budgets.
  • Cross-Functional Alignment: Coordinate across Pharmacology, DMPK, Toxicology, Safety, Bioanalysis, CMC, Quality, Translational Medicine, and Regulatory for clinical readiness.
  • Translational Science: Translate nonclinical pharmacology and exposure-response data into starting dose, escalation strategies, biomarker plans, and PoM/PoC hypotheses.
  • Regulatory & Supply Readiness: Ensure GMP supply chain readiness and lead operational aspects of IND/CTA submissions, health authority interactions, dose-escalation processes, and risk mitigations (under GLP/GMP/GCP).

Clinical Development & Proof of Concept (PoC)

  • Trial Execution: Design and deliver high-quality early-phase studies testing key hypotheses to generate decision-quality data on safety, tolerability, PK/PD, target engagement, and efficacy.
  • Data Integration & Adaptation: Adapt dose, schedule, cohort, indication, and endpoint decisions based on emerging clinical, translational, and safety data.
  • Later-Stage Hand-Off: Maintain a clear pathway from PoC to late-stage development and registration (endpoints, comparators, regulatory path).

Integrated Project Planning & Risk Management

  • Program Ownership: Own the integrated clinical development plan, critical paths, dependencies, and budgets in partnership with cross-functional leadership.
  • Risk & Governance: Proactively identify scientific, regulatory, operational, and commercial risks; establish mitigation strategies and balance speed with quality, safety, and compliance.

Communication & Stakeholder Management

  • Strategic Representation: Serve as the primary clinical spokesperson internally (presenting strategies and investment proposals to senior leadership) and externally (KOLs, development partners, and BD due diligence).

Qualifications, Education & Experience

Essential

  • Education: MD or MD-PhD (or equivalent medical qualification) in a relevant clinical discipline with a strong background in immune-mediated diseases or related areas.
  • Experience: 7–10+ years of biotech/pharma clinical development experience, with demonstrated leadership of global early-phase programs (FIH to Phase 2a PoC).
  • Technical Mastery: Deep understanding of end-to-end drug development (nonclinical, clinical, translational science, regulatory, CMC, safety, DMPK/clinical pharmacology).
  • Vendor & Regulatory Expertise: Proven track record in CRO governance, global regulatory filing requirements, trial design, medical/safety monitoring, and data interpretation.
  • Leadership: Strategic thinking, stage-gate governance experience, cross-functional influencing, and ability to thrive in a fast-paced biotech environment.

Preferred Qualifications

  • Domain experience in immunological diseases (dermatology, rheumatology, gastroenterology, respiratory) and relevant therapeutic modalities (biologics, antibodies, multispecifics, oral modalities).
  • Proven track record taking a program through PoC into late-stage development.
  • Experience with IND/CTA submissions across major global health authorities (US, China, Europe).
  • Background in external partnerships, licensing, BD due diligence, or alliance management.

Skills & Competencies

Additional Information

The Company

Ailux is an innovative biotechnology company harnessing AI to accelerate breakthrough biologic therapies in difficult immune-mediated diseases and improve the lives of patients with significant unmet medical need.

Built on intelligent design and guided by people who care about transforming healthcare, our technology is redefining what is possible in biologics development, from how we select targets to how we engineer the molecules.Ailux’s vision is to light the path to new cures and fundamentally change our approach to science and drug development to redefine current treatment paradigms.

We look to continue unlocking the potential of disease biology, integrate AI-enabled biologics development, and deliver effective clinical execution.Backed by an experienced leadership team, leading scientific advisors, a highly multidisciplinary organization, and strategic partnerships in biopharma, Ailux is approaching a key inflection point as its first wave of therapeutic programs advance toward clinical development.

This is an opportunity to play a vital role in leading programs from pre-clinical development into the clinic and through clinical proof-of-concept, shaping the pipeline and development culture of a rapidly growing biotechnology company.

Ideal Candidate Profile